Hemali Sangani
Thermaissance — Advanced Medical Textiles for Infection Control and Thermal Stability Across Healthcare
Thermaissance is a medical textile innovation company focused on improving infection control, patient comfort, and thermal stability across healthcare environments.
Our proprietary textile platform integrates broad-spectrum antimicrobial protection with adaptive thermoregulation, engineered directly into reusable medical fabrics—designed for continuous clinical use without coatings, leaching agents, or disposable dependency.
Thermaissance products are CE-marked Class I medical devices under EU MDR 2017/745, developed to meet the safety, durability, and performance expectations of modern hospitals and surgical environments.
Our technology is applied across a wide range of hospital textiles including clinical scrubs, patient gowns, blankets, bed linens, neonatal wraps, and infection-control fabrics for operating rooms and high-risk wards. Antimicrobial efficacy has been validated against multi-drug-resistant organisms such as MRSA, VRE, CRE, Acinetobacter, and Candida, addressing key contributors to healthcare-associated infections (HAIs).
In neonatal care—where thermal regulation is critical—our solutions have been evaluated through government-hospital clinical studies, demonstrating improved thermal stability and reduced cold stress in NICU and SNCU settings. These studies serve as clinical validation of our platform’s performance in one of the most demanding care environments.
By combining material science, regulatory compliance, and real-world clinical evidence, Thermaissance delivers a scalable medical textile platform suitable for both high-acuity hospitals and resource-constrained healthcare systems globally.
Thermaissance is a medical textile innovation company focused on improving infection control, patient comfort, and thermal stability across healthcare environments.
Our proprietary textile platform integrates broad-spectrum antimicrobial protection with adaptive thermoregulation, engineered directly into reusable medical fabrics—designed for continuous clinical use without coatings, leaching agents, or disposable dependency.
Thermaissance products are CE-marked Class I medical devices under EU MDR 2017/745, developed to meet the safety, durability, and performance expectations of modern hospitals and surgical environments.
Our technology is applied across a wide range of hospital textiles including clinical scrubs, patient gowns, blankets, bed linens, neonatal wraps, and infection-control fabrics for operating rooms and high-risk wards. Antimicrobial efficacy has been validated against multi-drug-resistant organisms such as MRSA, VRE, CRE, Acinetobacter, and Candida, addressing key contributors to healthcare-associated infections (HAIs).
In neonatal care—where thermal regulation is critical—our solutions have been evaluated through government-hospital clinical studies, demonstrating improved thermal stability and reduced cold stress in NICU and SNCU settings. These studies serve as clinical validation of our platform’s performance in one of the most demanding care environments.
By combining material science, regulatory compliance, and real-world clinical evidence, Thermaissance delivers a scalable medical textile platform suitable for both high-acuity hospitals and resource-constrained healthcare systems globally.
